Royal Fund Management LLC Sells 3,433 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

Royal Fund Management LLC trimmed its stake in Omega Healthcare Investors, Inc. (NYSE:OHI) by 9.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 34,750 shares of the real estate investment trust’s stock after selling 3,433 shares during the period. Royal Fund Management LLC’s holdings in Omega Healthcare Investors were worth $1,066,000 as of its most recent SEC filing.

A number of other large investors have also recently bought and sold shares of OHI. Nordwand Advisors LLC acquired a new position in Omega Healthcare Investors in the first quarter worth $27,000. Resurgent Financial Advisors LLC acquired a new position in Omega Healthcare Investors in the fourth quarter worth $27,000. GPS Wealth Strategies Group LLC acquired a new position in shares of Omega Healthcare Investors during the first quarter valued at $34,000. Coastal Investment Advisors Inc. acquired a new position in shares of Omega Healthcare Investors during the fourth quarter valued at $48,000. Finally, Chilton Capital Management LLC acquired a new position in shares of Omega Healthcare Investors during the first quarter valued at $50,000. 65.50% of the stock is currently owned by institutional investors.

Analyst Ratings Changes

OHI has been the topic of several research reports. StockNews.com raised Omega Healthcare Investors from a “sell” rating to a “hold” rating in a research note on Friday, August 25th. Truist Financial upped their price target on Omega Healthcare Investors from $29.00 to $33.00 in a research note on Wednesday, June 21st. Wells Fargo & Company upped their price target on Omega Healthcare Investors from $32.00 to $33.00 and gave the company an “equal weight” rating in a research note on Monday, August 7th. Royal Bank of Canada initiated coverage on Omega Healthcare Investors in a research note on Monday, September 11th. They set a “sector perform” rating and a $33.00 price target on the stock. Finally, Mizuho raised Omega Healthcare Investors from a “neutral” rating to a “buy” rating and increased their target price for the company from $31.00 to $35.00 in a research note on Friday, September 8th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $31.77.

Omega Healthcare Investors Stock Down 1.4 %

Shares of Omega Healthcare Investors stock opened at $32.94 on Tuesday. Omega Healthcare Investors, Inc. has a 1 year low of $25.61 and a 1 year high of $33.57. The business has a 50-day moving average of $31.82 and a two-hundred day moving average of $29.76. The company has a market capitalization of $8.07 billion, a P/E ratio of 32.29 and a beta of 0.99. The company has a debt-to-equity ratio of 1.39, a current ratio of 5.55 and a quick ratio of 5.55.

Omega Healthcare Investors Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, August 15th. Shareholders of record on Monday, July 31st were issued a $0.67 dividend. The ex-dividend date of this dividend was Friday, July 28th. This represents a $2.68 annualized dividend and a dividend yield of 8.14%. Omega Healthcare Investors’s dividend payout ratio (DPR) is currently 262.75%.

Omega Healthcare Investors Profile

Omega is a REIT that invests in the long-term healthcare industry, primarily in skilled nursing and assisted living facilities. Its portfolio of assets is operated by a diverse group of healthcare companies, predominantly in a triple-net lease structure. The assets span all regions within the U.S., as well as in the U.K.